— Know what they know.
Not Investment Advice

AMRX Short Interest

Amneal Pharmaceuticals, Inc.
1W: +8.1% 1M: +4.6% 3M: +12.2% YTD: +69.3% 1Y: +103.2% 3Y: +517.9% 5Y: +278.1%
$21.44
+0.42 (+2.00%)
 
Weekly Expected Move ±4.0%
$19 $20 $20 $21 $22
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 71 · $6.8B mcap · 144M float · 1.77% daily turnover · Short 59% of daily vol
Credit Risk of going bust: lower than 58% of companies Debt: 29.0% of company value Bonds: $58.6M held by 128 funds, 178 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.60 (down 97%), Amneal Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $2.79B against a stock market value of $6.85B.
Distance to default 5.94 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.39B (short-term plus half of long-term), stock volatility 35.6%; Altman Z 2.53. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Short Volume Summary

2026-10-26
65.7%
Short Ratio
of total volume
61.0%
20-Day Avg
58.6%
50-Day Avg
▲ Rising
5-Day Trend
0.4M
Short Volume
0.6M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 386,767 567,987 68.1%
NYSE 9,026 33,343 27.1%
BATS 532 1,650 32.2%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms